A brand new study from the POINT job and KORFOR exhibits that the usage of the solid pain-relieving opioid oxycodone has substantially amplified in Norwegian hospitals and primary healthcare providers in the last 10 several years. The analyze is posted within the European Journal of Ache.
– Fra min kliniske hverdag har jeg også erfaring med at fastlegene kanskje er litt mer forsiktige. En forskjell her er at sykehusene har en annen pasientpopulasjon og en mer spisset kompetanse på smertebehandling. De ser også pasienter more than en kortere periode enn fastlegene.
This research located key distinctions in full opioid use and substance-specific prescribing patterns, reflecting varied pain management methods across Scandinavia. Modifying use designs recommend evolving prescribing methods and achievable shifts within the goal group for opioid pain therapy.
The venture will Assess the impact of the knowledge-dependent teaching intervention targeted at basic practitioners.
Ifølge Eirik Haarr har funnene flere aspekter som er relevante for både sykehusleger og fastleger, i tillegg til å ha et helsetjenesteperspektiv:
In its place, variations in procurement contracts may possibly Participate in a role: All through this era, the volume of procurement agreements for morphine in hospitals drastically reduced, whilst the number of agreements for oxycodone elevated.
Additionally, There exists a deficiency of sturdy proof demonstrating that long-phrase therapy of Persistent pain with opioids is efficient. Extensive-expression use can result in serious Negative effects, such as the chance of overdose and dependancy.
Researchers have also seemed nearer at achievable explanations. The rise cannot be attributed to increased action in hospitals.
Oksykodon var sentral i utviklingen av opioidepidemien i United states og kan være assosiert med høyere risiko for avhengighet og overdose ifølge nyere studier1. I Norge er det anbefalt å bruke morfin som førstevalg blant sterke opioider2.
Det ble observert en moderat samvariasjon mellom bruk på sykehus og forskrivning i primærhelsetjenesten. Anbudsavtaler for morfin på sykehus gikk ned med eighty prosent i perioden, mens avtalene for oksykodon forble stabile.
Fastlegene har den fulle bredde av pasienter – også de pasientene som ikke fikk god nok smertelindring på sykehus. Adult men forskjellene mellom sykehusleger og fastleger kan gå begge veier når det gjelder forskriving, understreker Haarr, som selv er allmennlege ved Byhaugen legesenter i Stavanger to dager i uken.
Success Healthcare facility oxycodone use elevated by sixty seven.0% and first treatment prescribing rose by 86.5%. Morphine use amplified by twelve.6% in hospitals but reduced by 23.two% in Most important treatment. A reasonable covariation (Pearson's r = 0.48) between healthcare facility use and primary treatment prescribing was observed. Medical center tender agreements for morphine declined by eighty%, even though All those for oxycodone remained stable. Conclusions Oxycodone more info use substantially amplified relative to morphine in Norwegian hospitals and primary care. Prescription designs display reasonable covariation, suggesting a possible link among medical center and first treatment prescribing, though causality remains uncertain. Tender agreements could lead to prescribing traits in hospitals, with probable associations in Main care. Importance This analyze is the initial to supply quantitative evidence of covariation between in-healthcare facility use and first care opioid prescribing throughout a countrywide healthcare system. Regardless of tips favoring morphine, oxycodone prescribing carries on to rise in Norway, with marked geographical variation. By linking procurement knowledge, prescription patterns and tender agreements, our results emphasize the need to consider medical center practices and structural variables when addressing opioid prescribing. These results present new insights into prospective levers for opioid stewardship throughout treatment concentrations.
Det ble mottatt sixty one svar, responsraten var 32 %. Fastlegene besvarte spørsmålene ut fra én konkret pasient de hadde søkt refusjon for. Resultater: Gjennomsnittlig dosering per dag var 76 mg orale morfinekvivalenter (OMEQ). Samtidig bruk av legemidler fra reseptgruppe A eller B i tillegg til opioider forekom hos 53 % (n = 31) av pasientene. I gruppen der pasienten hadde slik samtidig bruk var 41 % (n = 13) av fastlegene enig eller delvis enig i at den medikamentelle behandlingen var hensiktsmessig. I gruppen der pasienten kun brukte opioider, mente 72 % av fastlegene det samme. Konklusjon: Ordningen med individuell refusjon av opioider på blå resept mot langvarige smertetilstander er ingen garanti for at pasienten er sikret forsvarlig eller hensiktsmessig medikamentell behandling.
Researchers have analyzed the trends in using morphine and oxycodone from 2010 to 2021. In addition they investigated whether or not adjustments in the use of both of these substances in hospitals could possibly be relevant to developments in Principal healthcare.